Australia's Cann Global rises as JV partner gets Canadian export approval

Cann Global

30/03/2021 02:24

** Shares of medical cannabis co Cann Global  CGB.AX  rise
as much as 12.5% to A$0.009, their highest since March 22
    ** Co says Canada's health regulator has granted an export
permit to its joint venture partner, Canntab Therapeutics Ltd
 PILL.CD , allowing the sale of Canntab's hard pills in
Australia (https://bit.ly/3w9Yr70)
    ** About 32.4 mln shares change hands, compared with the
30-day average of about 28.2 mln shares
    ** Stock has risen 14.3% this year, as of last close

 (Reporting by Soumyajit Saha in Bengaluru)
 ((Soumyajit.Saha@thomsonreuters.com;))